Related Experiment Video
Updated: Apr 18, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
A global microRNA screen identifies regulators of the ErbB receptor signaling network
Annabell Bischoff, Michaela Bayerlová, Michaela Strotbek
1Institute of Cell Biology and Immunology, University of Stuttgart, Allmandring 31, Stuttgart, 70569, Germany. monilola.olayioye@izi.uni-stuttgart.de.
Background:
The growth factor heregulin (HRG) potently stimulates epithelial cell survival and proliferation through the binding of its cognate receptor ErbB3 (also known as HER3). ErbB3-dependent signal transmission relies on the dimerization partner ErbB2, a receptor tyrosine kinase that is frequently overexpressed and/or amplified in breast cancer cells. Substantial evidence suggests that deregulated ErbB3 expression also contributes to the transformed phenotype of breast cancer cells.
Results:
By genome-wide screening, we identify 43 microRNAs (miRNAs) that specifically impact HRG-induced activation of the PI3K-Akt pathway. Bioinformatic analysis combined with experimental validation reveals a highly connected molecular miRNA-gene interaction network particularly for the negative screen hits. For selected miRNAs, namely miR-149, miR-148b, miR-326, and miR-520a-3p, we demonstrate the simultaneous downregulation of the ErbB3 receptor and multiple downstream signaling molecules, explaining their efficient dampening of HRG responses and ascribing to these miRNAs potential context-dependent tumor suppressive functions.
Conclusions:
Given the contribution of HRG signaling and the PI3K-Akt pathway in particular to tumorigenesis, this study not only provides mechanistic insight into the function of miRNAs but also has implications for future clinical applications.
Insights
Researchers identified 43 microRNAs (miRNAs) regulating heregulin (HRG) signaling. Specific miRNAs downregulate ErbB3 receptor, suggesting potential tumor suppressive functions in breast cancer by impacting the PI3K-Akt pathway.
Area of Science:
- Molecular biology
- Cancer research
- Signal transduction
Background:
- Heregulin (HRG) promotes epithelial cell survival and proliferation via ErbB3 (HER3) receptor.
- ErbB3 signaling involves ErbB2, a receptor tyrosine kinase often amplified in breast cancer.
- Aberrant ErbB3 expression contributes to breast cancer cell transformation.
Purpose of the Study:
- To identify microRNAs (miRNAs) that regulate heregulin (HRG)-induced signaling.
- To elucidate the molecular mechanisms by which miRNAs impact HRG/ErbB3 pathways.
- To explore the potential tumor suppressive roles of identified miRNAs in breast cancer.
Main Methods:
- Genome-wide screening to identify regulatory miRNAs.
- Bioinformatic analysis to construct miRNA-gene interaction networks.
- Experimental validation of miRNA functions and target genes, including ErbB3 receptor levels.
Main Results:
- Identified 43 miRNAs affecting HRG-induced PI3K-Akt pathway activation.
- Revealed a complex miRNA-gene interaction network, particularly for negative regulators.
- Demonstrated that miR-149, miR-148b, miR-326, and miR-520a-3p downregulate ErbB3 and downstream effectors.
Conclusions:
- Specific miRNAs can effectively dampen HRG responses by targeting ErbB3.
- These miRNAs exhibit context-dependent tumor suppressive functions.
- Findings offer mechanistic insights into miRNA roles and suggest potential clinical applications in targeting HRG signaling in cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Master Transcription Regulators
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of the Unfolded Protein Response

